Literature DB >> 1702365

High affinity insulin binding and insulin receptor-effector coupling: modulation by Ca2+.

P F Williams1, I D Caterson, G J Cooney, R R Zilkens, J R Turtle.   

Abstract

Insulin binding and insulin stimulated amino acid and glucose uptake were determined in cultured HTC hepatoma cells in the presence of Ca2+ and ruthenium red (RR) in order to further characterise the putative calcium binding site on the receptor. These ions increased insulin receptor high affinity binding and the sensitivity of these responses to insulin. The insulin concentration required to half-maximally stimulate amino acid uptake decreased significantly from 26.9 +/- 5.8 ng/ml to 6.0 +/- 1.3 ng/ml in the presence of 10 mM Ca2+ and to 1.3 +/- 0.5 ng/ml in the presence of RR. The effect of Ca2+ and RR was more pronounced on insulin stimulated glucose uptake. These agents also increased receptor-effector coupling, reducing the percentage of occupied receptors required for maximal insulin stimulation of amino acid uptake from 10.8% in control cells to 3.4 and 1.4% in the presence of Ca2+ and RR respectively. The receptor occupancy required to produce maximal insulin responses on glucose uptake decreased from 20% (control) to 3.8% (Ca2+ and RR). We hypothesize that since Ca2+ and RR have similar effects, that occupation of Ca2+ binding sites on the receptor produces a conformational change in the insulin receptor which increases insulin receptor affinity, insulin sensitivity and acts on an early post-receptor event responsible for coupling binding to insulin action.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702365     DOI: 10.1016/0143-4160(90)90031-o

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  16 in total

Review 1.  The role of calcium in the prevention of cardiovascular disease--a review of observational studies and randomized clinical trials.

Authors:  Susanne Rautiainen; Lu Wang; JoAnn E Manson; Howard D Sesso
Journal:  Curr Atheroscler Rep       Date:  2013-11       Impact factor: 5.113

Review 2.  Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials.

Authors:  Lu Wang; JoAnn E Manson; Howard D Sesso
Journal:  Am J Cardiovasc Drugs       Date:  2012-04-01       Impact factor: 3.571

Review 3.  The Role of Vitamin D in the Prevention of Type 2 Diabetes: To D or Not to D?

Authors:  Edith Angellotti; Anastassios G Pittas
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

4.  Effect of calcium treatment on blood parameters, gonadal development and the structure of bone in immature female rats.

Authors:  Natalia El-Merhie; Ismail Sabry; Mahmoud Balbaa
Journal:  J Physiol Biochem       Date:  2011-12-03       Impact factor: 4.158

Review 5.  The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.

Authors:  Anastassios G Pittas; Joseph Lau; Frank B Hu; Bess Dawson-Hughes
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

Review 6.  Vitamin D and diabetes.

Authors:  Joanna Mitri; Anastassios G Pittas
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

7.  Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men.

Authors:  Tianying Wu; Walter C Willett; Edward Giovannucci
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

8.  Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D.

Authors:  S Kumar; M Davies; Y Zakaria; E B Mawer; C Gordon; A O Olukoga; A J Boulton
Journal:  Postgrad Med J       Date:  1994-06       Impact factor: 2.401

9.  Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women's Health Study.

Authors:  Raquel Villegas; Yu-Tang Gao; Qi Dai; Gong Yang; Hui Cai; Honglan Li; Wei Zheng; Xiao Ou Shu
Journal:  Am J Clin Nutr       Date:  2009-02-18       Impact factor: 7.045

10.  Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin.

Authors:  S Bevan; S Hothi; G Hughes; I F James; H P Rang; K Shah; C S Walpole; J C Yeats
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.